Directorio de personas
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Grado: Doctor/a

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Publicaciones

  • Carrio, I; Pieri, PL; Narula, J; Prat, L; Riva, P; Pedrini, L; Pretolani, E; Caruso, G; Sarti, G; Estorch, M; Berna, L; Riambau, V; Matias-Guiu, X; Pak, C; Ditlow, C; Chen, F; Khaw, BA

    Noninvasive localization of human atherosclerotic lesions with indium 111-labeled monoclonal Z2D3 antibody specific for proliferating smooth muscle cells

    Journal Of Nuclear Cardiology 5 551-557. .

    [doi:10.1016/S1071-3581(98)90108-8]

  • Chico, A; Gallart, L; Mato, E; Mayoral, C; Martin-Campos, JM; Catasus, L; Rodriguez-Espinosa, J; Matias-Guiu, X; Blanco-Vaca, F; de Leiva, A

    A novel germline mutation in exon 5 of the multiple endocrine neoplasia type 1 gene

    Journal Of Molecular Medicine-Jmm 76 837-839. .

    [doi:10.1007/s001090050288]

  • Catasus, L; Matias-Guiu, X; Machin, P; Munoz, J; Prat, J

    BaX somatic frameshift mutations in endometrioid adenocarcinomas of the endometrium: Evidence for a tumor progression role in endometrial carcinomas with microsatellite instability

    LABORATORY INVESTIGATION 78 1439-1444. .

  • Catasus, L; Machin, P; Matias-Guiu, X; Prat, J

    Microsatellite instability in endometrial carcinomas: Clinicopathologic correlations in a series of 42 cases

    HUMAN PATHOLOGY 29 1160-1164. .

    [doi:10.1016/S0046-8177(98)90430-0]

  • Matias-Guiu, X; Pons, C; Prat, J

    Mullerian inhibiting substance, alpha-inhibin, and CD99 expression in sex cord-stromal tumors and endometrioid ovarian carcinomas resembling sex cord-stromal tumors

    HUMAN PATHOLOGY 29 840-845. .

    [doi:10.1016/S0046-8177(98)90454-3]

  • Matias-Guiu, X; Prat, J

    Molecular pathology of ovarian carcinomas

    VIRCHOWS ARCHIV 433 103-111. .

    [doi:10.1007/s004280050224]

  • Mato, E; Matias-Guiu, X; Chico, A; Webb, SM; Cabezas, R; Berna, L; De Leiva, A

    Somatostatin and somatostatin receptor subtype gene expression in medullary thyroid carcinoma

    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 83 2417-2420. .

    [doi:10.1210/jc.83.7.2417]

  • Matias-Guiu, X; Lerma, E; Prat, J

    Current topics in pathology of gynecologic tumors - a selective review

    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY 6 121-134. .

    [doi:10.1177/106689699800600301]

  • Albareda, M; Puig-Domingo, M; Wengrowicz, S; Soldevila, J; Matias-Guiu, X; Caballero, A; Chico, A; De Leiva, A

    Clinical forms of presentation and evolution of diffuse sclerosing variant of papillary carcinoma and insular variant of follicular carcinoma of the thyroid

    Thyroid 8 385-391. .

    [doi:10.1089/thy.1998.8.385]

  • Matias-Guiu, X; Machin, P; Pons, C; Lagarda, E; De Leiva, A; Prat, J

    Sustentacular cells occur frequently in the familial form of medullary thyroid carcinoma

    JOURNAL OF PATHOLOGY 184 420-423. .

    [doi:10.1002/(SICI)1096-9896(199804)184:4<420::AID-PATH1231>3.0.CO;2-R]

  • Cuatrecasas, M; Erill, N; Musulen, E; Costa, I; Matias-Guiu, X; Prat, J

    K-ras mutations in nonmucinous ovarian epithelial tumors - a molecular analysis and clinicopathologic study of 144 patients

    CANCER 82 1088-1095. .

    [doi:10.1002/(SICI)1097-0142(19980315)82:6<1088::AID-CNCR12>3.3.CO;2-A]

  • Chivite, A; Matias-Guiu, X; Pons, C; Algaba, F; Prat, J

    Inhibin a expression in adrenal neoplasms - a new immunohistochemical marker for adrenocortical tumors

    APPL IMMUNOHISTO M M 6 42-49. .

    [doi:10.1097/00022744-199803000-00008]

Proyectos

  • Unravelling the molecular and phenotypic complexity of endometriosis through new models and omics integration: towards a personalized clinical management
  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU